Cargando…

Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction

AIMS/INTRODUCTION: The present study was undertaken to determine vascular endothelial impairment and endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus and erectile dysfunction (ED). MATERIALS AND METHODS: A total of 100 type 2 diabetic men were enrolled. Flow‐mediated dil...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Miho, Tamemoto, Hiroyuki, Otani, Taeko, Jinbo, Sachimi, Ikeda, Nahoko, Kawakami, Masanobu, Ishikawa, San‐e
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015432/
https://www.ncbi.nlm.nih.gov/pubmed/24843618
http://dx.doi.org/10.1111/j.2040-1124.2012.00230.x
_version_ 1782315337498230784
author Murata, Miho
Tamemoto, Hiroyuki
Otani, Taeko
Jinbo, Sachimi
Ikeda, Nahoko
Kawakami, Masanobu
Ishikawa, San‐e
author_facet Murata, Miho
Tamemoto, Hiroyuki
Otani, Taeko
Jinbo, Sachimi
Ikeda, Nahoko
Kawakami, Masanobu
Ishikawa, San‐e
author_sort Murata, Miho
collection PubMed
description AIMS/INTRODUCTION: The present study was undertaken to determine vascular endothelial impairment and endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus and erectile dysfunction (ED). MATERIALS AND METHODS: A total of 100 type 2 diabetic men were enrolled. Flow‐mediated dilatation (FMD) and anaerobic threshold (AT) were measured. Also, EPCs in the peripheral blood were determined by flow cytometry. RESULTS: In the 42 ED diabetic patients, FMD and AT were significantly less than those in the 58 patients with normal erectile function (FMD 2.84 vs 3.82%, P = 0.038, and AT 11.2 vs 12.7 mL/kg/min, P = 0.022). Exercise tolerance significantly increased the number of EPCs in the patients with and without ED (49–60 cells/100 μL, P = 0.015, and 72–99 cells/100 μL, P = 0.003). In the diabetic patients without autonomic neuropathy, FMD was significantly reduced in the patients with ED than those without ED (P = 0.015). In response to exercise tolerance, the number of EPCs increased in both the diabetic patients with ED (P = 0.003) and without ED (P = 0.007). In contrast, in the diabetic patients with autonomic neuropathy, there was no difference in FMD between the patients with and without ED. The exercise tolerance increased the number of EPCs in the patients without ED (P = 0.023), but it disappeared in those with ED. CONCLUSIONS: ED diabetic patients have endothelial impairment during the early period of diabetic complications, whose deranged endothelial function is concomitantly repaired by promoting bone marrow‐derived EPCs.
format Online
Article
Text
id pubmed-4015432
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Wiley-Blackwell
record_format MEDLINE/PubMed
spelling pubmed-40154322014-05-19 Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction Murata, Miho Tamemoto, Hiroyuki Otani, Taeko Jinbo, Sachimi Ikeda, Nahoko Kawakami, Masanobu Ishikawa, San‐e J Diabetes Investig Articles AIMS/INTRODUCTION: The present study was undertaken to determine vascular endothelial impairment and endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus and erectile dysfunction (ED). MATERIALS AND METHODS: A total of 100 type 2 diabetic men were enrolled. Flow‐mediated dilatation (FMD) and anaerobic threshold (AT) were measured. Also, EPCs in the peripheral blood were determined by flow cytometry. RESULTS: In the 42 ED diabetic patients, FMD and AT were significantly less than those in the 58 patients with normal erectile function (FMD 2.84 vs 3.82%, P = 0.038, and AT 11.2 vs 12.7 mL/kg/min, P = 0.022). Exercise tolerance significantly increased the number of EPCs in the patients with and without ED (49–60 cells/100 μL, P = 0.015, and 72–99 cells/100 μL, P = 0.003). In the diabetic patients without autonomic neuropathy, FMD was significantly reduced in the patients with ED than those without ED (P = 0.015). In response to exercise tolerance, the number of EPCs increased in both the diabetic patients with ED (P = 0.003) and without ED (P = 0.007). In contrast, in the diabetic patients with autonomic neuropathy, there was no difference in FMD between the patients with and without ED. The exercise tolerance increased the number of EPCs in the patients without ED (P = 0.023), but it disappeared in those with ED. CONCLUSIONS: ED diabetic patients have endothelial impairment during the early period of diabetic complications, whose deranged endothelial function is concomitantly repaired by promoting bone marrow‐derived EPCs. Wiley-Blackwell 2012-07-24 2012-12-20 /pmc/articles/PMC4015432/ /pubmed/24843618 http://dx.doi.org/10.1111/j.2040-1124.2012.00230.x Text en Copyright © 2012 Asian Association for the Study of Diabetes and Wiley Publishing Asia Pty Ltd
spellingShingle Articles
Murata, Miho
Tamemoto, Hiroyuki
Otani, Taeko
Jinbo, Sachimi
Ikeda, Nahoko
Kawakami, Masanobu
Ishikawa, San‐e
Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title_full Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title_fullStr Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title_full_unstemmed Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title_short Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
title_sort endothelial impairment and bone marrow‐derived cd34(+)/133(+) cells in diabetic patients with erectile dysfunction
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015432/
https://www.ncbi.nlm.nih.gov/pubmed/24843618
http://dx.doi.org/10.1111/j.2040-1124.2012.00230.x
work_keys_str_mv AT muratamiho endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT tamemotohiroyuki endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT otanitaeko endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT jinbosachimi endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT ikedanahoko endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT kawakamimasanobu endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction
AT ishikawasane endothelialimpairmentandbonemarrowderivedcd34133cellsindiabeticpatientswitherectiledysfunction